PILOTS PROJECTS AND FUNDED PROPOSALS 1998
|
INVESTIGATOR |
PROTOCOL NAME |
SUPPORT/FACILITIES |
YEAR |
| Josefina Romaguera, MD | Collaborative Study Comparing the Effectiveness of Thyroxine and Steroids versus Steroids Alone in the Reduction of Morbidity | Outpatient | 1998-1999 |
| Esther A. Torres, MD, FACP | Intron A + Ribavirin for the treatment of patients with Interferon-Refractory or Interferon-Relapsed Chronic Hepatitis C | Outpatient Biostatistical Laboratory Support | 1998 |
| Esther A. Torres, MD, FACP | Seroprevalence of the Helicobacter pylori Antibodies in Puerto Rican Patients with Inflammatory Bowel Disease: A Pilot Case-Control Study | Laboratory Support | 1998 |
| Caroline Chantry, MD | Dose Escalating Trial of N-Acetylcysteine and Vitamin C Alone and in Combination for Treatment of Glutathione Deficiency in Pediatric HIV Disease - Pilot Study | Outpatient | 1998 |
| Estela S. Estapé, Ph.D. | Digoxin-Like Immnoreactive Factor (DLIF): Potential Marker for Stroke-Proneness? - Pilot Study | Outpatient | 1998 |
| Inés García,MD | Neural Tube Defects and a 5,10 Methylenetetrahydofolate Reductase Defect in the Puerto Rican Population - Pilot Study | Outpatient Biostatistical Support | 1998-ongoing |
| Edna Mora,MD | Does Responsiveness of Human Breast Carcinoma Cells to IL-3 Increase Their Bone-Metastatic Potential? Pilot Study | Outpatient | 1998 |
| Esther A. Torres, MD, FACP | Prevalence of Schistosoma mansoni Antibodies in Puerto Ricans with Inflammatory Bowel Disease: A Pilot Study - Pilot Study | Biostatistical Laboratory Support | 1998 |
| Gloria Reyes Báez, MD | Comparative Study of The Effectiveness of Thyroxine and Steroids on Reduction of Neonatal Morbidity: Outcome at 18 Months Follow Up-Pilot Study Pilot Study | Outpatient Biostatistical Support | 1998-2004 |
| Federico Rodríguez, MD | Autonomic Dysfunction in Patients with Chronic Liver Disease | Biostatistical Support | 1998 |
| Esther A. Torres, MD, FACP | Serologic Markers of Inflammatory Bowel Disease | Outpatient Laboratory Support | 1998 |
| Lilliam González de Pijem, MD | Diabetes Prevention Trial-Type I | Outpatient Laboratory Support | 1998-2004 |
| Carmen Serrano,MD | Efficacy of Olanzapine in the Treatment of Chronic TIC Disorders in a Group of Puerto Rican Patients | Outpatient | 1998 |
| Rafael Quiñones, PhD | Non-Syndromic Hearing Loss | Outpatient Laboratory Support | 1998 |
| Mario García Palmieri, MD | Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) | Outpatient Laboratory Support | 1998-2003 |
| Esther A. Torres, MD, FACP | A Six or A Twelve Months, Randomized, Double-Masked, Placebo-Controlled, Three Arm Study to Evaluate the Safety and Efficacy of ISIS 2302 in Steroid-Dependent Chrohn’s Disease | Outpatient Laboratory Support | 1998-2000 |
| Inés García, MD | Folate Metabolism in the Puerto Rican Female Population - Pilot Study | Outpatient Biostatistical Support | 1998-2002 |
| Nilsa Toledo, DMD | Oral Health Status and Treatment Needs in a Population of Hispanic Children and Adolescents with HIV Disease | Outpatient Biostatistical & Dental Support | 1998 |
| Gishlaine Alfonso, MD | Peripheral Neuropathy in Hepatitis C Virus Infection in a Hispanic Population: A Pilot Study | Biostatistical Support | 1998 |
| John Flynn, MD | Study Involving Revision of Results of Spinal Surgery in Adolescent Idiopathic Scoliosis | Biostatistical Support | 1998 |
| Esther A. Torres, MD, FACP | Intron A + Ribavirin for Treatment of Patients with Chronic Hepatitis C Not Previously Treated with Interferon | Outpatient Laboratory Support | 1998-1999 |
| Esther Torres, MD, FACP | Folic Acid Supplementation as Prevention of Hemolysis in Patients with Chronic Hepatitis C Receiving Interferon and Ribavirin Therapy | Biostatistical Laboratory Support | 1998-2001 |
| Inés García, MD | Methylenetetrahydrofolate Reductase Common Mutations Screening in Puerto Ricans Newborns | Biostatistical Support | 1998 |
| Carmen Serrano, MD | Earlier vs Later Levodopa in Parkinson's Disease | Outpatient Laboratory Support | 1998-1999 |
